APOA1 and ovarian cancer: APOA1 and APOA1 mimetic peptides directly reduced the viability and proliferation of ID8 tumor cells and cis-platinum–resistant human ovarian cancer cell lines by the binding and removal of the mitogenic lipid lysophosphatidic acid (4).